Ancient drug may prove wonders for heart

2014-03-31 20:29


Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Washington - A drug that was used in the time of the pharaohs for rheumatism has proven highly effective in treating recurrent bouts of pericarditis, an inflammation of the sac surrounding the heart, according to findings of a new clinical trial.

The ancient medicine, colchicine, which has also been used for centuries as an anti-inflammatory agent for acute gout, was tested against placebo in a 240-patient pericarditis trial.

The rate of recurring pericarditis was nearly halved for those taking colchicine compared with placebo, according to data presented on Sunday at the annual scientific sessions of the American College of Cardiology in Washington.

The condition, which causes sharp chest pain, recurred in 42.5% of those taking dummy pills, compared with 21.6% of those who got colchicine.

Moreover, after three days of treatment, 19.2% of patients taking the drug had symptoms, compared with more than 44% of those given placebos.

And those taking placebos, on average, had 0.63 recurrences, compared to 0.28 recurrences for those on colchicine.

With such fewer recurrences, the drug reduced the rate of hospitalisations to 1.7%, from 10% in the placebo group, potentially cutting healthcare costs at a time when pressure is mounting to limit costly hospital readmissions.

Although colchicine has been used for decades to treat pericarditis, following favourable trends seen in earlier trials, this was the first large formal multi-centre study to examine use of the drug for multiple recurrences of the condition.

The favourable results will increase confidence in use of the medicine for pericarditis, researchers said.

Patients in the study received 0.5 milligrams of the drug either once or twice daily depending on their weight in addition to commonly used anti-inflammatory drugs such as aspirin or ibuprofen.

No serious side effects were associated with use of colchicine, researchers said, but gastrointestinal issues were reported in about eight percent of patients.

The reasons for pericarditis that repeatedly recurs once the original cause has been treated are not well understood, but potential causes are infections, kidney disease, cancer and heart surgery, researchers said.

"Health care providers should feel confident with the use of colchicine as a first line drug in patients with multiple recurrences of pericarditis", both for its safety and effectiveness, said Dr Massimo Imazio, a cardiologist with Maria Vittoria Hospital in Torino, Italy, who led the trial.

Imazio said the study affirms that colchicine can be added to traditional treatments, such as anti-inflammatories and corticosteroids, and thereby provide an affordable treatment with few side effects.
Read more on:    us  |  health

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.